Skip to main content

Kevin D. Accola, MD

Kevin D. Accola, MD

Cardiovascular and Thoracic Surgeon

Cardiovascular

Kevin Accola

Overview

Dr. Kevin D. Accola, MD is a board-certified internal medicine, hematology and oncology physician. Dr. Accola earned his medical degree from the University of Illinois at Chicago and completed his internship and medical residency at Baylor College of Medicine & Emory University School of Medicine. To date, he has performed approximately 9,000 cardiac surgical procedures, of which 2,400 (currently 300+ cases per year) involved heart valve operations. As an established member of the surgical community, Dr. Accola is a member of many medical organizations, including but not limited to, the Patient Advocacy Council, the Society of Thoracic Surgeons, the Florida Medical Association, the Florida Society of Thoracic Cardiovascular Surgeons Council,and the American College of Cardiology. Dr. Accola's cardiac specialties include mitral valve repair, aortic valve procedures, and ascending aortic aneurysm. His clinical interests comprise new valvular technology, cardiac protective drugs, and critical care studies.

Education & Training

Education

Rush Medical College

Residency

Baylor College Of Medicine; Emory University

Fellowship

Emory University Hospital

Specialty

Thoracic & Cardiovascular Surgery

Board Certifications

American Board of Thoracic Surgery

Associated Clinical Trials

NCT03706833

CLASP IID/IIF - A prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter mitral valve repair with the Edwards PASCAL Transcatheter Mitral Valve Repair System compared to Abbott Mitraclip in patients with degenerative mitral regurgitation.

Icon for trial | 2018-07 CLASP IID/IIF - A prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter mitral valve repair with the Edwards PASCAL Transcatheter Mitral Valve Repair System compared to Abbott Mitr

The goal of this study is to assess the safety and performance of the PASCAL System in patients with symptomatic degenerative mitral regurgitation (DMR). Up to 300 participants will take part in this randomized study at up to 7 ...

NCT04142658

PROACT Xa - A prospective, randomized, active (warfarin) controlled, parallel-arm clinical trial to determine if patients with an On-X aortic valve can be maintained safely and effectively on the factor Xa inhibitor apixaban

Icon for trial | ONX1801.000-C PROACT Xa - A prospective, randomized, active (warfarin) controlled, parallel-arm clinical trial to determine if patients with an On-X aortic valve can be maintained safely and effectively on the factor Xa inhibitor apixaban

This study is currently enrolling.

You are being asked to take part in this research study because you are at least 18 years old, have had an On-X mechanical valve implanted in the aortic position at least 3 months (90 days) ago, are currently receiving warfarin ...